Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Case Studies

Case Study: Seizures and Hypoglycemia

  1. Michael R. Brennan, DO and
  2. Fred W. Whitehouse, MD
Clinical Diabetes 2012 Jan; 30(1): 23-24. https://doi.org/10.2337/diaclin.30.1.23
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

PRESENTATION

A.S. is a 64-year-old man admitted to the nephrology service for dizziness and hypotension after dialysis. During his hospital stay, he experienced labile blood glucose levels and had a suspected hypoglycemic seizure. The endocrine service was consulted to assist with these findings.

The patient has a history of previous stroke, remote alcohol abuse, and end-stage renal disease requiring hemodialysis 3 days/week and is awaiting a kidney transplant. He has had type 2 diabetes for 25 years and has been treated with insulin for 10 years.

During the past year and a half, he reports having had two seizures. His family witnessed the first seizure and reports that he was hyperglycemic at that time. Additionally, the patient reports an event during which he suddenly “passed out” and was “out of it” for the rest of the day. At home, he takes 6 units of aspart insulin with meals and 12 units of glargine insulin in the morning. He weighs 84 kg, and his last A1C result was 6.7%.

During the hospitalization, he was placed on his home insulin regimen plus a hospital preprandial correction dose of insulin. The correction dose was 2 units of aspart for blood glucose readings that were 151–200 mg/dl, increasing by 2 units of aspart for every 50 mg/dl increase in blood glucose. While in the hospital, he felt nauseated and did not eat. That afternoon, he had a witnessed seizure. He was stabilized, and routine laboratory testing was performed. His blood glucose measured 42 mg/dl during the seizure.

QUESTIONS

  1. Does hypoglycemia induce seizure?

  2. What is the frequency of unconscious events in patients with diabetes?

  3. Do patients with diabetes experience seizures for reasons other than hypoglycemia?

  4. What variables determine when a seizure may occur in patients with diabetes?

COMMENTARY

Health care providers and patients became aware of the relationship between insulin, seizures, and coma almost with the advent of this miracle drug. In the findings of Frederick Banting's seminal paper on insulin,1 he noted that rabbits given the pancreatic extract (insulin) became hyper-excitable and had clonic convulsive seizures lasting for several minutes. Banting concluded that, “subcutaneous injections of dextrose solutions antidote the convulsions and other symptoms, so that the animal (rabbit) in a few minutes becomes restored to a tolerably normal condition.”

In the late 1920s and early 1930s, Manfred Sakel and others used insulin in an innovative manner to treat patients with morphine withdrawal and other neuropsychiatric illness by inducing seizure and coma. From 1930 to 1960, insulin coma therapy was performed on schizophrenic patients. Seizures occurred during these therapies ranging from total convulsions to only jerks and twitches.2,3 By the end of this experience with therapy, the doctrine that insulin therapy could induce seizure was well established.

Hypoglycemia should be in the differential diagnosis of any individual with seizures. Because diabetes is a condition that typically uses hypoglycemia-causing agents (insulin and oral hypoglycemic agents in the sulfonylurea and meglitinide drug classes), it is important to be aware that seizures in this population could be iatrogenic.

The Diabetes Control and Complications Trial (DCCT)4 reported the frequency of hypoglycemic “loss of consciousness” events in patients with type 1 diabetes. In the study's intensive therapy group, loss of consciousness events occurred at a rate of 16.3 episodes per 100 patient-years, which falls within the range of other reports.4

Although there have been some reports of the frequency of insulin-induced unconsciousness events, validating the formal relationship in a clinical setting may be difficult for several reasons. First, seizures are not always witnessed and are often reported after the fact. In children, 75% of hypoglycemic seizures are reported as occurring at night.5 Second, recording of blood glucose levels before, during, or after seizures rarely occurs. Without this information, it is difficult to determine whether a low blood glucose level was the cause of the seizure. Third, a long duration of diabetes is often accompanied by comorbid conditions associated with microvasular and macrovascular injuries. These injuries could be detrimental to nerve conduction and further confound the relationship between hypoglycemia, diabetes, and seizure. Finally, because of compensatory mechanisms in the body, particularly in type 2 diabetes, euglycemia or even hyperglycemia may occur during and after a seizure. These compensatory mechanisms make correlating the inciting hypoglycemic event difficult, even in a hospital setting.

Although hypoglycemia can induce seizures, other etiologies of seizures should not be overlooked in the diabetic population. A large Australian regional diabetes center found that the prevalence of epilepsy in children with type 1 diabetes was similar to that in the general population and noted that health care providers should not assume that a seizure in a type 1 diabetic patient is the result of hypoglycemia.6

Recently, continuous glucose monitoring (CGM) technology has allowed researchers to capture data furthering the understanding of hypoglycemia-induced seizures. Nighttime is the most vulnerable period for hypoglycemia because sleep blunts the counterregulatory responses to hypoglycemia, even in nondiabetic people.7 Patients with diabetes who have had seizures while wearing a CGM device in some cases display a CGM reading of < 60 mg/dl for more than 2 hours before the seizure occurred.5 The capturing of these seizure events on CGM suggests that several factors, including nocturnal timing, sleep status, and preceding duration of hypoglycemia, may be necessary to create the clinical event of a hypoglycemic seizure.

Type 1 diabetes accounts for a small proportion of total diabetes prevalence worldwide. Patients with type 2 diabetes also may have seizures from hypoglycemia, but medical literature on the subject is scant. This further implies that, although seizures and comas can be induced with excess insulin, the frequency with which these events occur in the general diabetic population appears to be low.

After his seizure, A.S. was transferred to the hospital's intensive care unit. While there, he had an electroencephalogram that showed some abnormal conduction pathways. He was euglycemic for the remainder of his hospitalization, his nausea resolved, and his hydration and volume status normalized; he was discharged to home in his usual state of health.

Neither the neurology nor the endocrinology service unequivocally stated that hypoglycemia caused his seizure because of his confounding past alcohol abuse, metabolic derangements with end-stage renal disease, and previous stroke with residual tissue injury noted on magnetic resonance imaging. He will be evaluated as an outpatient for a newly identified seizure disorder.

CLINICAL PEARLS

  • Insulin coma therapy performed in the past for schizophrenic patients clearly demonstrates that excessive exogenous insulin causes a decrease in blood glucose that induces seizures.

  • In seizing patients, particularly those taking insulin, sulfonylureas, or meglitinides, hypoglycemia-induced seizure should be considered. If clinically appropriate, a seizing patient should be administered glucose as a possible remedy.

  • Studies suggest that epilepsy occurs with the same frequency in people with diabetes as in the general population. It should not be assumed that a seizure in a patient with diabetes is caused by hypoglycemia; other neurological and metabolic causes should be considered.

  • It is difficult to establish a clear cause-and-effect relationship between hypoglycemia and seizures in the diabetic population. In the future, CGM technology may aid in the diagnosis.

  • Observations using CGM devices have demonstrated that hypoglycemic seizures may occur nocturnally, during sleep, and be precipitated by a prolonged duration of hypoglycemia.

Footnotes

  • Michael R. Brennan, DO, is an endocrine fellow and Fred W. Whitehouse, MD, is division head emeritus of Endocrinology, Diabetes, Bone and Mineral Disorders at Henry Ford Hospital in Detroit, Mich.

  • American Diabetes Association(R) Inc., 2012

REFERENCES

  1. ↵
    1. Banting FG,
    2. Best CH,
    3. Macleod JJR,
    4. Noble EC
    : The effect of pancreatic extract (insulin) on normal rabbits. Am J Physiol 62:162–176, 1922
    OpenUrlFREE Full Text
  2. ↵
    1. Doroshow D
    : Performing a cure for schizophrenia: insulin coma therapy on the ward. J Hist Med Allied Sci 62:212–243, 2007
    OpenUrl
  3. ↵
    1. Jones K
    : Insulin coma therapy in schizophrenia. J R Soc Med 93:147–149, 2000
    OpenUrlFREE Full Text
  4. ↵
    1. DCCT Research Group
    : Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271–286, 1997
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Buckingham B,
    2. Wilson DM,
    3. Lecher T,
    4. Hanas R,
    5. Kaiserman K,
    6. Cameron F
    : Duration of nocturnal hypoglycemia before seizures. Diabetes Care 31:2110–2112, 2008
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. O'Conell MA,
    2. Harvey AS,
    3. Mackay MT,
    4. Cameron FJ
    : Does epilepsy occur more frequently in children with type 1 diabetes? J Paediatr Child Health 44:586–589, 2008
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Jones TW,
    2. Porter P,
    3. Sherwin RS,
    4. Davis EA,
    5. O'Leary P,
    6. Frazer F,
    7. Byrne G,
    8. Stick S,
    9. Tamborlane WV
    : Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 338:1657–1662, 1998
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Clinical Diabetes: 30 (1)

In this Issue

January 2012, 30(1)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Case Study: Seizures and Hypoglycemia
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Case Study: Seizures and Hypoglycemia
Michael R. Brennan, Fred W. Whitehouse
Clinical Diabetes Jan 2012, 30 (1) 23-24; DOI: 10.2337/diaclin.30.1.23

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Case Study: Seizures and Hypoglycemia
Michael R. Brennan, Fred W. Whitehouse
Clinical Diabetes Jan 2012, 30 (1) 23-24; DOI: 10.2337/diaclin.30.1.23
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • PRESENTATION
    • QUESTIONS
    • COMMENTARY
    • CLINICAL PEARLS
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Isolation and Education During a Pandemic: Novel Telehealth Approach to Family Education for a Child With New-Onset Type 1 Diabetes and Concomitant COVID-19
  • Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes
  • Syndromic Conundrums in Diabetes: Seek and Ye Shall Find: The Dorfman-Chanarin Syndrome
Show more Case Studies

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.